Switch theme
Sign up to access all valuation multiples
Clariane SE operates nursing homes, post-acute and rehabilitation clinics, assisted living facilities, and home care services. Its operating segments are France, Germany, Italy, and Belgium. The majority of its revenue is generated in France. Its nursing homes offer long-term care and medical support for elderly people.
2003
60K+
LTM Revenue $6.1B
LTM EBITDA $1.2B
$10.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Clariane has a last 12-month revenue of $6.1B and a last 12-month EBITDA of $1.2B.
In the most recent fiscal year, Clariane achieved revenue of $6.0B and an EBITDA of $1.2B.
Clariane expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Clariane valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $5.7B | $6.0B | XXX | XXX | XXX |
| Gross Profit | $4.6B | $5.2B | XXX | XXX | XXX |
| Gross Margin | 82% | 87% | XXX | XXX | XXX |
| EBITDA | $1.1B | $1.2B | XXX | XXX | XXX |
| EBITDA Margin | 19% | 20% | XXX | XXX | XXX |
| Net Profit | $25.1M | -$120M | XXX | XXX | XXX |
| Net Margin | 0% | -2% | XXX | XXX | XXX |
| Net Debt | $4.3B | $4.4B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 25, 2025, Clariane's stock price is EUR 4 (or $4).
Clariane has current market cap of EUR 1.3B (or $1.5B), and EV of EUR 8.8B (or $10.0B).
See Clariane trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $10.0B | $1.5B | XXX | XXX | XXX | XXX | $-0.03 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 25, 2025, Clariane has market cap of $1.5B and EV of $10.0B.
Clariane's trades at 1.6x LTM EV/Revenue multiple, and 8.2x LTM EBITDA.
Analysts estimate Clariane's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Clariane and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $10.0B | XXX | XXX | XXX |
| EV/Revenue | 1.7x | XXX | XXX | XXX |
| EV/EBITDA | 8.3x | XXX | XXX | XXX |
| P/E | -24.4x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 14.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpClariane's NTM/LTM revenue growth is 5%
Clariane's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Clariane's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Clariane's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Clariane and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 11% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 25% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 86% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| National Healthcare Corp | XXX | XXX | XXX | XXX | XXX | XXX |
| Regis Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Maternus-Kliniken | XXX | XXX | XXX | XXX | XXX | XXX |
| Addus HomeCare | XXX | XXX | XXX | XXX | XXX | XXX |
| Amedisys | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Clariane acquired XXX companies to date.
Last acquisition by Clariane was XXXXXXXX, XXXXX XXXXX XXXXXX . Clariane acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Clariane founded? | Clariane was founded in 2003. |
| Where is Clariane headquartered? | Clariane is headquartered in France. |
| How many employees does Clariane have? | As of today, Clariane has 60K+ employees. |
| Who is the CEO of Clariane? | Clariane's CEO is Ms. Sophie Boissard. |
| Is Clariane publicy listed? | Yes, Clariane is a public company listed on PAR. |
| What is the stock symbol of Clariane? | Clariane trades under CLARI ticker. |
| When did Clariane go public? | Clariane went public in 2006. |
| Who are competitors of Clariane? | Similar companies to Clariane include e.g. National Healthcare Corp, Regis Healthcare, Maternus-Kliniken, Addus HomeCare. |
| What is the current market cap of Clariane? | Clariane's current market cap is $1.5B |
| What is the current revenue of Clariane? | Clariane's last 12-month revenue is $6.1B. |
| What is the current EBITDA of Clariane? | Clariane's last 12-month EBITDA is $1.2B. |
| What is the current EV/Revenue multiple of Clariane? | Current revenue multiple of Clariane is 1.6x. |
| What is the current EV/EBITDA multiple of Clariane? | Current EBITDA multiple of Clariane is 8.2x. |
| What is the current revenue growth of Clariane? | Clariane revenue growth between 2023 and 2024 was 6%. |
| Is Clariane profitable? | Yes, Clariane is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
